Addressing healthcare inequities in Israel by eliminating prescription drug copayments

American Journal of Managed Care

Volumn 17, Issue 7, 2011, Pages

  Elhayany, Asher ^a   Vinker, Shlomo ^b  

^a MEIR MEDICAL CENTER   (Israel)

^b CLALIT HEALTH SERVICES   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BLOOD PRESSURE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISRAEL; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; SOCIOECONOMICS;

AGED; COHORT STUDIES; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; FINANCING, GOVERNMENT; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISRAEL; MALE; MIDDLE AGED; POVERTY; PRESCRIPTION DRUGS; PRESCRIPTION FEES; PROSPECTIVE STUDIES;

EID: 79960795521     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kaidar N, Bin Nun G. International Comparison of Health Care Systems: Israel and OECD Member States 1970-2005. Jerusalem: Dept of Health Economics, Ministry of Health, State of Israel; 2007:45.
2. Braithwaith RS, Rosen AB. Linking cost sharing to value: an unrivaled yet unrealized public health opportunity. Ann Intern Med. 2007;146(8):602-605. (Pubitemid 351650541)
3. Nyman JA. Is 'moral hazard' inefficient? the policy implications of a new theory. Health Aff (Millwood). 2004;23(5):194-199. (Pubitemid 39310497)
4. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349-2359. (Pubitemid 43801280)
5. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285(4):421-429. (Pubitemid 32097260)
6. Bae SJ, Paltiel AD, Fuhlbrigge AL, Weiss, ST, Kuntz KM. Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic Medicaid population. Value Health. 2008;11(1):110-118. (Pubitemid 351160881)
7. Barron J, Wahl P, Fisher M, Plauschinat C. Effect of prescription copayments on adherence and treatment failure with oral antidiabetic medications. P T. 2008;33(9):532-553.
8. Federman AD, Adams AS, Ross-Degnan D, Soumerai SB, Ayanian JZ. Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease. JAMA. 2001;286(14):1732- 1739. (Pubitemid 33010259)
9. Johnson RE, Goodman MJ, Hornbrook MC, Eldredge MB. The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members. Health Serv Res. 1997;32(1):103-122. (Pubitemid 27172817)
10. Kass-Bartelmes BL, Bosco L. Prescription Drug Therapies: Reducing Costs and Improving Outcomes. Rockville, MD: Agency for Healthcare Research and Quality; 2008. Research in Action, issue 8. AHRQ publication 02-0045.
11. Roblin DW, Platt R, Goodman MJ, et al. Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care. 2005;43(10):951-959. (Pubitemid 41442460)
12. Kephart G, Skedgel C, Sketris I, Grootendorst P, Hoar J. Effect of copayments on drug use in the presence of annual payment limits. Am J Manag Care. 2007;13(6, pt 2):328-334. (Pubitemid 46983129)
13. Trivedi AN, Moloo H, Mor V. Increased ambulatory care copayments and hospitalizations among the elderly. N Engl J Med. 2010;362(4):320-328.
14. Mackenbach JP, Stirbu I, Roskam AJ, et al European Union Working Group on Socioeconomic Inequalities in Health. Socioeconomic inequalities in health in 22 European countries [published correction appears in N Engl J Med. 2008;359(12):e14]. N Engl J Med. 2008;358(23):2468-2481.
15. Bentur N, Gross R, Brammli-Greenberg S. Satisfaction with and access to community care of the chronically ill in Israel's health system. Health Policy. 2004;67(2):129-136. (Pubitemid 38068211)
16. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298(1):61-69. (Pubitemid 47026771)
17. Schoen MD, DiDomenico RJ, Connor SE, Dischler JE, Bauman JL. Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease. Pharmacotherapy. 2001;21(12):1455-1463. (Pubitemid 33117249)
18. Gemmill MC, Thomson S, Mossialos E. What impact do prescription drug charges have on efficiency and equity? evidence from high-income countries. Int J Equity Health. 2008;7:e12. http://www.ncbi.nlm. nih.gov/pmc/articles/ PMC2412871/?tool=pubmed. Accessed June 11, 2011.
19. Reuveni H, Sheizaf B, Elhayany A, et al. The effect of drug co-payment policy on the purchase of prescription drugs for children with infections in the community. Health Policy. 2002;62(1):1-13. (Pubitemid 34814971)
20. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22(6):864-871. (Pubitemid 46763978)
21. Lurk JT, DeJong DJ, Woods TM, Knell ME, Carroll CA. Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider setting. Am J Health Syst Pharm. 2004;61(3):267-272. (Pubitemid 39004622)
22. Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291(19):2344-2350. (Pubitemid 38656301)
23. Pilote L, Beck C, Richard H, Eisenberg MJ. The effects of cost-sharing on essential drug prescriptions, utilization of medical care and outcomes after acute myocardial infarction in elderly patients. CMAJ. 2002;167(3):246-252. (Pubitemid 34920559)
24. Rosen B, Merkur S. Israel: health system review. Health Care Systems Transition. 2009;11(2):1-226.
25. Gross R, Brammli-Greenberg S, Waitzberg R. Public Opinion of the Level of Service and Performance of the Health-Care System, 2007. Jerusalem, Israel: Myers-JDC-Brookdale Institute. Research report RR-541-09.
26. Degani A, Degani R. Health Services Needs in Israel: the Center vs. the Periphery. Ramat Gan: Israeli Medical Association; April 2008.
27. Benoit SR, Fleming R, Philis-Tsimikas A, Ji M. Predictors of glycemic control among patients with type 2 diabetes: a longitudinal study. BMC Public Health. 2005;5:e36. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090595/?tool= pubmed. Accessed June 11, 2011.
28. Chiu CJ, Wray LA. Factors predicting glycemic control in middle-aged and older adults with type 2 diabetes. Prev Chronic Dis. 2010;7(1):A08. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811503/?tool=pubmed. Accessed June 11, 2011.
29. Porath A, Rabinowitz G, Raskin Segal A, Weitzman R. Quality Indicators for Community Health Care in Israel: 2004-2006 Public Report. Tel Hashomer: Israel Institute for Policy and Health Services Research Health Council, Ministry of Health; April 2007.
30. Gladwell M. The moral-hazard myth: the bad idea behind our failed health-care system. The New Yorker. August 29, 2005. www.newyorker.com/archive/ 2005/08/29/050829fa-fact?currentPage=all#ixzz0dVcua1Ec. Accessed October 13, 2009.
31. Fendrick AM, Smith DG, Chernew ME, Shah SN. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. Am J Manag Care. 2001;7(9):861-867. (Pubitemid 32904146)
32. Maciejewski ML, Bryson CL, Perkins M, et al. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Am J Manag Care. 2010;16(1):e20-e34. http://www.ajmc.com/login. Accessed June 11, 2011.
33. Kleinke JD. Access versus excess: value-based cost sharing for prescription drugs. Health Aff (Millwood). 2004;23(1):34-47. (Pubitemid 39115291)